Dagklis Ioannis E, Aletras Vasilis H, Tsantaki Efthymia, Orologas Anastasios, Niakas Dimitrios
Faculty of Social Sciences, Hellenic Open University , Patras.
Department of Business Administration, University of Macedonia , Thessaloniki.
Neurol Int. 2016 Sep 30;8(3):6416. doi: 10.4081/ni.2016.6416.
An ongoing debate on decision and cost-utility analyses is whether to use preferences of general public or patients. The aim of this study was to replicate the valuation procedure of the multi-attribute utility generic measure, 15D, using a sample of multiple sclerosis (MS) patients and to assess its psychometric properties. Consecutive outpatient MS patients were recruited from two MS centers in Greece. The three-stage valuation procedure was applied and, with the use of elicited preference weights, an MS patients' algorithm was developed. The original Finnish value set derived from healthy individuals was also used to calculate scores and a comparison between the two algorithms was made. A total of 64 MS patients were evaluated. The 15D scores obtained with the MS patients' valuation algorithm were higher than the original one. The derived utilities differed significantly with respect to age, depressive symptoms, Expanded Disability Status Scale score and clinical form. MS patients indicated as most important domains mobility, mental functioning and vitality. Cronbach's alpha was estimated 0.876 and correlations between relevant dimensions of the instruments were moderate to high. The 15D was generally feasible and reliable in patients with MS and the valuation system yielded acceptable psychometric properties.
关于决策分析和成本效用分析的一个持续争论是,究竟应该采用普通公众还是患者的偏好。本研究的目的是,使用多发性硬化症(MS)患者样本,复制多属性效用通用测量方法15D的估值程序,并评估其心理测量特性。从希腊的两个MS中心招募连续就诊的门诊MS患者。应用了三阶段估值程序,并利用得出的偏好权重开发了一个MS患者算法。源自健康个体的原始芬兰价值集也被用于计算得分,并对两种算法进行了比较。总共评估了64名MS患者。通过MS患者估值算法获得的15D得分高于原始算法。得出的效用在年龄、抑郁症状、扩展残疾状态量表得分和临床类型方面存在显著差异。MS患者指出,最重要的领域是活动能力、心理功能和活力。克朗巴赫α系数估计为0.876,工具相关维度之间的相关性为中度到高度。15D在MS患者中总体上是可行且可靠的,该估值系统产生了可接受的心理测量特性。